why choose us

First received: October 14, 2024

Clinical Trial: A Clinical Study of Enlicitide in Participants With Severe Renal Impairment (MK-0616-032)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy

Study Type: INTERVENTIONAL


Official Title: An Open-Label, Multiple-Dose Clinical Study to Evaluate the Pharmacokinetics of Enlicitide in Participants With Severe Renal Impairment

Brief Summary: Researchers have designed a new study medicine called enlicitide decanoate as a new way to lower the amount of low-density lipoprotein cholesterol (LDL-C) in a person's blood.Enlicitide decanoate will be called "enlicitide" from this point forward, The purpose of this study is to learn what happens to enlicitide in a person's body over time (a pharmacokinetic (PK) study).Researchers will compare what happens to enlicitide in the body when it is given to people with severe renal impairment…

Read more